Published in Clin Infect Dis on October 25, 2005
Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates. J Clin Microbiol (2007) 1.33
Emergence and disappearance of a virulent clone of Haemophilus influenzae biogroup aegyptius, cause of Brazilian purpuric fever. Clin Microbiol Rev (2008) 1.04
Use of bexB to detect the capsule locus in Haemophilus influenzae. J Clin Microbiol (2011) 1.03
Poor clinical outcome for meningitis caused by Haemophilus influenzae serotype A strains containing the IS1016-bexA deletion. J Infect Dis (2010) 1.03
Haemophilus influenzae type a infection and its prevention. Infect Immun (2007) 0.97
Assessment of carriage of Haemophilus influenzae type a after a case of invasive disease. Clin Infect Dis (2006) 0.90
Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a. Clin Vaccine Immunol (2010) 0.85
The epidemiology of invasive disease due to Haemophilus influenzae serotype a in the Canadian North from 2000 to 2010. Int J Circumpolar Health (2013) 0.85
Characterization of nasopharyngeal isolates of type b Haemophilus influenzae from Delhi. Indian J Med Res (2012) 0.81
Variant IS1016 insertion elements in invasive Haemophilus influenzae type b isolates harboring multiple copies of the capsulation b locus. Clin Infect Dis (2006) 0.77
Haemophilus influenzae type a as a cause of paediatric septic arthritis. JMM Case Rep (2016) 0.75
Invasive Haemophilus influenzae disease in the vaccine era in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz (2017) 0.75
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48
Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med (2005) 12.75
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis (2010) 8.37
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med (2006) 7.68
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis (2007) 6.45
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA (2008) 6.13
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet (2006) 5.56
FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis (2004) 5.53
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis (2007) 5.36
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA (2005) 5.29
Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med (2009) 4.38
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis (2002) 4.08
Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med (2003) 3.54
Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA (2004) 3.05
Bacterial meningitis in the United States, 1998-2007. N Engl J Med (2011) 2.99
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA (2006) 2.93
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med (2013) 2.78
The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol (2009) 2.68
Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis (2009) 2.56
Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis (2009) 2.53
Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. J Infect Dis (2011) 1.91
Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis (2012) 1.91
Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis (2004) 1.85
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons. J Infect Dis (2012) 1.80
FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrob Agents Chemother (2010) 1.79
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol (2012) 1.68
Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol (2010) 1.57
Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999. Clin Infect Dis (2004) 1.55
Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infect Dis (2010) 1.53
Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect Immun (2005) 1.53
Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics (2008) 1.51
Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis (2003) 1.48
Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009. Clin Infect Dis (2014) 1.47
Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics (2002) 1.47
Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis (2011) 1.42
Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics (2007) 1.36
Invasive listeriosis in the Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009: further targeted prevention needed for higher-risk groups. Clin Infect Dis (2012) 1.34
Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett (2003) 1.34
Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health (2010) 1.33
Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates. J Clin Microbiol (2007) 1.33
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS (2010) 1.32
NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis (2014) 1.31
Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics (2010) 1.26
Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children. Clin Infect Dis (2012) 1.26
Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol (2009) 1.25
Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet (2005) 1.23
Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States. J Clin Microbiol (2009) 1.20
Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J (2008) 1.19
Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease. J Infect Dis (2002) 1.16
Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis (2011) 1.15
Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis (2005) 1.15
Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. J Infect Dis (2003) 1.13
Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia. Pediatr Infect Dis J (2015) 1.12
Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. J Infect (2010) 1.12
Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010. J Infect Dis (2013) 1.11
Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Pediatr Infect Dis J (2013) 1.10
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant. J Infect Dis (2011) 1.08
Genetic analysis of the capsule locus of Haemophilus influenzae serotype f. Infect Immun (2003) 1.07
Increase in rates of hospitalization due to laboratory-confirmed influenza among children and adults during the 2009-10 influenza pandemic. J Infect Dis (2012) 1.06
Complete sequence of the cap locus of Haemophilus influenzae serotype b and nonencapsulated b capsule-negative variants. Infect Immun (2003) 1.05
Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J Virol (2007) 1.05
Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis (2013) 1.03
Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic. Clin Infect Dis (2012) 1.02
Clostridium difficile infection among children across diverse US geographic locations. Pediatrics (2014) 1.01
Population-based surveillance for Yersinia enterocolitica infections in FoodNet sites, 1996-1999: higher risk of disease in infants and minority populations. Clin Infect Dis (2004) 1.00
Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases. Am J Obstet Gynecol (2011) 0.99
A population-based investigation of invasive vancomycin-resistant Enterococcus infection in metropolitan Atlanta, Georgia, and predictors of mortality. Infect Control Hosp Epidemiol (2007) 0.99
Invasive pneumococcal pneumonia and respiratory virus co-infections. Emerg Infect Dis (2012) 0.97
Infection with community-onset Staphylococcus aureus and influenza virus in hospitalized children. Pediatr Infect Dis J (2009) 0.97
Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States. J Infect Dis (2013) 0.96
Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period. Vaccine (2012) 0.92
The burden of influenza hospitalizations in infants from 2003 to 2012, United States. Pediatr Infect Dis J (2014) 0.91
Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response. Vaccine (2003) 0.91
Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia. J Infect Dis (2013) 0.90
Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clin Infect Dis (2002) 0.89
Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis (2003) 0.89
An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States. PLoS One (2012) 0.89
Association of IS1016 with the hia adhesin gene and biotypes V and I in invasive nontypeable Haemophilus influenzae. Infect Immun (2008) 0.88
Lack of heteroresistance among Staphylococcus aureus isolates with vancomycin MICs of 2 micrograms per milliliter by automated testing. J Clin Microbiol (2009) 0.87
Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a. Clin Vaccine Immunol (2010) 0.85
Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes. J Infect (2012) 0.84
Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections. Emerg Infect Dis (2015) 0.83
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Pediatrics (2008) 0.83
Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J (2014) 0.83
Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgrad Med (2009) 0.82
Invasive infection with multidrug-resistant Salmonella enterica serotype typhimurium definitive type 104 among HIV-infected adults. Clin Infect Dis (2005) 0.81
Twenty Years of Active Bacterial Core Surveillance. Emerg Infect Dis (2015) 0.81
Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations. J Infect Dis (2012) 0.80
Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferral. Clin Vaccine Immunol (2011) 0.79
Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates. Emerg Infect Dis (2015) 0.79
Training in Infectious Disease Epidemiology through the Emerging Infections Program Sites. Emerg Infect Dis (2015) 0.79
Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of age: an emerging infections program study. Pediatr Infect Dis J (2014) 0.77
Methicillin-resistant Staphylococcus aureus empyema Necessitatis in a breast-fed neonate. Pediatr Infect Dis J (2014) 0.75